1. Witteveen H, van den Berg P, Vermeulen G. Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach. The journal of headache and pain. 2017 Dec;18(1):1-5.
2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954-76.
3. Kaur, D. K. K. (2018). Menstrual Migraine-A Mini Review: Nessa J Gynecology.
4. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
5. Somerville BW (1972) The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22:355–365
6. Cupini LM, Corbelli I, Sarchelli P. Menstrual migraine: what it is and does it matter?. Journal of Neurology. 2020 Jan 28:1-9.
7. Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: Review. Headache. 2017;57:194-208.
8. Martelletti, P., & Guglielmetti, M. (2020). Approaching the appropriate pharmacotherapy of menstrual migraine.
9. Martin VT, Ballard J, Diamond MP et al. Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium. J Womens Health (Larchmt) 2014;23:389-96.
10. Cady RK, Diamond ML, Diamond MP et al. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache 2011;51:664-73
11. Silberstein SD, Stirpe JC. COX inhibitors for the treatment of migraine. Expert Opin Pharmacother 2014;15:1863-74.
12. Allais G, Chiarle G, Sinigaglia S, Benedetto C. Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opinion on Pharmacotherapy. 2018 Jan 22;19(2):123-36.
13. Hu Y, Guan X, Fan L, Jin L. Triptans in prevention of menstrual migraine: A systematic review with meta-analysis. J Headache Pain. 2013;30:7.
14. Silberstein SD, Holland S, Freitag F, et al. Evidencebased guideline update: Pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337-1345.
15. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study. Neurology. 2006;67:2159-2163.
16. Newman LC, Lipton RB, Lay CL et al. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998;51:307-9
17. Sances G, Martignoni E, Fioroni L et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990;30:705-9
18. Allais G, Bussone G, De Lorenzo C et al. Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci 2007;28:S225-8
19. Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res 2000;5:176-182
20. Granella F, Allais G, Benedetto C. Cyclo-oxygenase-2 inhibitors as short-term prophylaxis of menstrually related migraine. A pilot study. Cephalalgia 2003;23:731
21. D’Alessandro R, Gamberini G, Lozito A et al. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. Cephalalgia 1983;3:156-8
22. Facchinetti F, Sances G, Volpe A et al. Hypothalamus-pituitary-ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment. Cephalgia 1983;3:S159-62
23. de Lignières B, Vincens M, Mauvais-Jarvis P et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 1986;293:1540
24. MacGregor EA, Frith A, Ellis J et al. Prevention of menstrual attacks of migraine: a doubleblind placebo-controlled crossover study. Neurology 2006;67:2159-63
25. Allais G, Sanchez del Rio M, Diener HC et al. perimenstrual migraines and their response to preventive therapy with topiramate. Cephalalgia 2011;31:152-60
26. G Allais, Giulia Chiarle, Silvia Sinigaglia & Chiara Benedetto (2017): Menstrual Migraine: a review of current and developing pharmacotherapies for women, Expert Opinion on Pharmacotherapy
27. Edelman A, Micks E, Gallo MF et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database of Syst Rev 2014;29;(7):CD004695.
28. Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part 2. Headache 2006;46(3):365-86
29. Jayaraman A, Pike CJ. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurons. J Neuroendocrinol. 2009; 21(1):77-81
30. Merki-Feld GS, Imthurn B, Dubey R et al. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives? J Obstet
31. Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002;56(6):283-8
32. Ferrante F, Fusco E, Calabresi P et al. Phyto-oestrogens in the prophylaxis of menstrual migraine. Clin Neuropharmacol. 2004;27(3):137-40’
33. Diener HC, Tassorelli C, Dodick DW, et al. Guidelines of the international headache society for controlled trials of acute treatment of migraine attacks in adults: fourth edition. Cephalalgia. 2019;39:687–710.
34. Diener HC, Tassorelli C, Dodick DW, et al. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalgia. 2020;1026-1044
35. Nappi, Rossella E., Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco, and Cristina Tassorelli. 2022. "Role of Estrogens in Menstrual Migraine" Cells 11, no. 8: 1355. https://doi.org/10.3390/cells11081355
36. Ornello, Raffaele, Eleonora De Matteis, Chiara Di Felice, Valeria Caponnetto, Francesca Pistoia, and Simona Sacco. 2021. "Acute and Preventive Management of Migraine during Menstruation and Menopause" Journal of Clinical Medicine 10, no. 11: 2263. https://doi.org/10.3390/jcm10112263